These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31381511)

  • 21. TPPU protects tau from H
    Yao ES; Tang Y; Liu XH; Wang MH
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):785-790. PubMed ID: 27924507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Okadaic acid-induced Tau phosphorylation in rat brain: role of NMDA receptor.
    Kamat PK; Rai S; Swarnkar S; Shukla R; Ali S; Najmi AK; Nath C
    Neuroscience; 2013 May; 238():97-113. PubMed ID: 23415789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1,8-Cineole Ameliorates Advanced Glycation End Products-Induced Alzheimer's Disease-like Pathology In Vitro and In Vivo.
    An F; Bai Y; Xuan X; Bian M; Zhang G; Wei C
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35745036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of glycogen synthase kinase-3 reverses tau hyperphosphorylation induced by Pin1 down-regulation.
    Xiong YS; Wang DL; Tan L; Wang X; Chen LM; Gong CX; Wang JZ; Zhu LQ
    CNS Neurol Disord Drug Targets; 2013 May; 12(3):436-43. PubMed ID: 23469846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of rutaecarpine on Alzheimer's disease-like cognitive impairments induced by high glucose in rats].
    Chen JG; Wu YG; Li X
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2019 Feb; 35(2):178-182. PubMed ID: 31250613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation.
    Li XH; Lv BL; Xie JZ; Liu J; Zhou XW; Wang JZ
    Neurobiol Aging; 2012 Jul; 33(7):1400-10. PubMed ID: 21450369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GSK-3β and ERK1/2 incongruously act in tau hyperphosphorylation in SPS-induced PTSD rats.
    Wei Z; Mahaman YAR; Zhu F; Wu M; Xia Y; Zeng K; Yang Y; Liu R; Wang JZ; Shu X; Wang X
    Aging (Albany NY); 2019 Sep; 11(18):7978-7995. PubMed ID: 31548435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SIL1 Rescued Bip Elevation-Related Tau Hyperphosphorylation in ER Stress.
    Liu ZC; Chu J; Lin L; Song J; Ning LN; Luo HB; Yang SS; Shi Y; Wang Q; Qu N; Zhang Q; Wang JZ; Tian Q
    Mol Neurobiol; 2016 Mar; 53(2):983-994. PubMed ID: 25575678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
    Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
    Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
    Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
    J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori filtrate induces Alzheimer-like tau hyperphosphorylation by activating glycogen synthase kinase-3β.
    Wang XL; Zeng J; Yang Y; Xiong Y; Zhang ZH; Qiu M; Yan X; Sun XY; Tuo QZ; Liu R; Wang JZ
    J Alzheimers Dis; 2015; 43(1):153-65. PubMed ID: 25079798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model.
    Qi L; Ke L; Liu X; Liao L; Ke S; Liu X; Wang Y; Lin X; Zhou Y; Wu L; Chen Z; Liu L
    Eur J Pharmacol; 2016 Jul; 783():23-32. PubMed ID: 27131827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model.
    Long ZM; Zhao L; Jiang R; Wang KJ; Luo SF; Zheng M; Li XF; He GQ
    CNS Neurosci Ther; 2015 Nov; 21(11):887-97. PubMed ID: 26385876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effects of lithium treatment for spatial memory deficits induced by tau hyperphosphorylation in splenectomized rats.
    Tan WF; Cao XZ; Wang JK; Lv HW; Wu BY; Ma H
    Clin Exp Pharmacol Physiol; 2010 Oct; 37(10):1010-5. PubMed ID: 20659131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex-Specific Neurotoxicity of Dietary Advanced Glycation End Products in APP/PS1 Mice and Protective Roles of Trehalose by Inhibiting Tau Phosphorylation via GSK-3β-TFEB.
    Zhou HH; Luo L; Zhai XD; Chen L; Wang G; Qin LQ; Yu Z; Xin LL; Wan Z
    Mol Nutr Food Res; 2021 Dec; 65(23):e2100464. PubMed ID: 34669246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bushen-Huatan-Yizhi formula reduces spatial learning and memory challenges through inhibition of the GSK-3β/CREB pathway in AD-like model rats.
    Yang SS; Shi HY; Zeng P; Xia J; Wang P; Lin L
    Phytomedicine; 2021 Sep; 90():153624. PubMed ID: 34216932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease.
    Sharma N; Tramutola A; Lanzillotta C; Arena A; Blarzino C; Cassano T; Butterfield DA; Di Domenico F; Perluigi M; Barone E
    Neurobiol Dis; 2019 May; 125():176-189. PubMed ID: 30738142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exogenous brain-derived neurotrophic factor attenuates cognitive impairment induced by okadaic acid in a rat model of Alzheimer's disease.
    Xu AH; Yang Y; Sun YX; Zhang CD
    Neural Regen Res; 2018 Dec; 13(12):2173-2181. PubMed ID: 30323150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NAP Protects against Tau Hyperphosphorylation Through GSK3.
    Ivashko-Pachima Y; Gozes I
    Curr Pharm Des; 2018; 24(33):3868-3877. PubMed ID: 30417779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.